Insider Trading Activity Nymox Pharmaceutical Corporation (NASDAQ:NYMX) – Director Bought 15,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Nymox Pharmaceutical Corporation (NASDAQ:NYMX)

James George Robinson , Director of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reportedly Bought 15,000 shares of the company’s stock at an average price of 3.72 for a total transaction amount of $55,800.00 SEC Form

Insider Trading History For Nymox Pharmaceutical Corporation (NASDAQ:NYMX)

  • On 9/3/2015 James George Robinson, Director, bought 100,000 with an average share price of $2.25 per share and the total transaction amounting to $225,000.00.View SEC Filing
  • On 12/4/2015 James George Robinson, Director, bought 110,000 with an average share price of $3.44 per share and the total transaction amounting to $378,400.00.View SEC Filing
  • On 12/11/2015 James George Robinson, Director, bought 46,812 with an average share price of $3.51 per share and the total transaction amounting to $164,310.12.View SEC Filing
  • On 12/18/2015 James George Robinson, Director, bought 63,334 with an average share price of $3.56 per share and the total transaction amounting to $225,469.04.View SEC Filing
  • On 12/23/2015 James George Robinson, Director, bought 29,854 with an average share price of $3.54 per share and the total transaction amounting to $105,683.16.View SEC Filing
  • On 12/28/2015 James George Robinson, Director, bought 6,000 with an average share price of $3.79 per share and the total transaction amounting to $22,740.00.View SEC Filing
  • On 12/29/2015 James George Robinson, Director, bought 14,000 with an average share price of $3.55 per share and the total transaction amounting to $49,700.00.View SEC Filing

    • Analyst Ratings For Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
    These are No ratings tracked in the last 12 months. .
    The current consensus rating for Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is N/A (Score: NaN) with a consensus target price of N/A

    Recent Trading Activity for Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
    Shares of Nymox Pharmaceutical Corporation closed the previous trading session at 3.67 down -0.09 -2.39% with 59,331 shares trading hands.